CXCR1 and neoplasm: Higher expressions of CXCR1, CXCR2, and CXCR4 with their ligands CXCL5, CXCL8, and CXCL12 appear to be associated with tumor angiogenesis, metastasis, and poor survival in NSCLCs (5,22–26).